Mezger Markus, Wozniok Iwona, Blockhaus Christian, Kurzai Oliver, Hebart Holger, Einsele Hermann, Loeffler Juergen
Medizinische Klinik II, Universität Würzburg, 97070 Würzburg, Germany.
Antimicrob Agents Chemother. 2008 Jul;52(7):2644-6. doi: 10.1128/AAC.01618-07. Epub 2008 Apr 21.
Mycophenolic acid (MPA) is used clinically to prevent graft rejection but may increase the risk of fungal infection. We observed that MPA enhanced the Aspergillus fumigatus-induced oxidative burst of polymorphonuclear neutrophils, but without a corresponding increase in fungal killing. Furthermore, MPA inhibited the proinflammatory cytokine response and maturation of dendritic cells.
霉酚酸(MPA)在临床上用于预防移植排斥反应,但可能会增加真菌感染的风险。我们观察到,MPA增强了烟曲霉诱导的多形核中性粒细胞的氧化爆发,但真菌杀伤能力并未相应增加。此外,MPA抑制了树突状细胞的促炎细胞因子反应和成熟。